Publications by authors named "Mike Gavrielides"

Claim this Profile
S
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.
Mary Y Wu, Scott T C Shepherd, Annika Fendler, Edward J Carr, Lewis Au, Mike Gavrielides

Cancer Cell· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.
Annika Fendler, Scott T C Shepherd, Lewis Au, Mary Wu, Ruth Harvey, Mike Gavrielides

Cell Rep Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Annika Fendler, Scott T C Shepherd, Lewis Au, Katalin A Wilkinson, Mary Wu, Mike Gavrielides

Cancer Cell· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
Annika Fendler, Scott T C Shepherd, Lewis Au, Mary Wu, Ruth Harvey, Mike Gavrielides

Lancet· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Annika Fendler, Scott T C Shepherd, Lewis Au, Katalin A Wilkinson, Mary Wu, Mike Gavrielides

Cancer Cell· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.
Annika Fendler, Scott T C Shepherd, Lewis Au, Katalin A Wilkinson, Mary Wu, Mike Gavrielides

Nat Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.
Annika Fendler, Scott T C Shepherd, Lewis Au, Katalin A Wilkinson, Mary Wu, Mike Gavrielides

Nat Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Annika Fendler, Lewis Au, Scott T C Shepherd, Fiona Byrne, Maddalena Cerrone, Mike Gavrielides

Nat Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Annika Fendler, Lewis Au, Scott T C Shepherd, Fiona Byrne, Maddalena Cerrone, Mike Gavrielides

Res Sq· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onco-STS: a web-based laboratory information management system for sample and analysis tracking in oncogenomic experiments.
Mike Gavrielides, Simon J Furney, Tim Yates, Crispin J Miller, Richard Marais

Source Code Biol Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis.
Simon J Furney, Samra Turajlic, Gordon Stamp, J Meirion Thomas, Andrew Hayes, Mike Gavrielides

Pigment Cell Melanoma Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis